July 14, 2021
Diabetes: New Medicines, New Monitoring
The field of diabetes mellitus is rapidly expanding. In the past decade several new medications and new glucose monitoring and insulin delivery systems have been developed and approved for use in clinical practice. It is challenging for non-endocrinologists to keep abreast with new literature and applications of new technology. This session will review the most relevant and current aspects of the management of diabetes mellitus.
Upon completion of this session, learners should be able to:
- Select pharmacologic agents that provide the most benefits to patients with diabetes in a personalized manner;
- Define the different types of diabetes technology and its clinical indications.
Julio Leey, MD
Dr. Leey is an Assistant Professor of Medicine at the University of Florida. He is the Director of Diabetes Clinic at the Malcolm Randall VA Medical Center (VA) and Diabetes Technology at University of Florida (UF) both in Gainesville, FL.
Dr Leey received his medical degree at Universidad Peruana Cayetano Heredia in his native Peru, followed by an Internal Medicine Residency at University of Louisville, KY and an endocrinology Fellowship at Washington University St Louis, MO.
His clinical practice focuses in all clinical aspects of diabetes mellitus, in particular diabetes technology, type 1 diabetes, Cystic Fibrosis-related diabetes, and artificial pancreas technology. His research focuses in diabetes technology and has VA funding to optimize the use of continuous glucose monitoring in rural settings.